Chroboczek, TomaszLacoste, MarieWackenheim, ChloeWackenheim, ChloeChallan-Belval, ThibautAmar, BenjaminBoisson, ThomasHubac, JasonLeduc, DominiqueMasse, ColleenDechaene, VictorTouhiri-Maximin, LaetitiaMegessier, SandrineLassale, Camille2021-01-152021Chroboczek T, Lacoste M, Wackenheim C, Challan-Belval T, Amar B, Boisson T, Hubac J, Leduc D. et al. Corticosteroids in patients with COVID-19: what about the control group? Clin Infect Dis. Corticosteroids in Patients With COVID-19: What About the Control. DOI: 10.1093/cid/ciaa7681058-4838http://hdl.handle.net/10230/46179application/pdfeng© Oxford University Press. This is a pre-copyedited, author-produced version of an article accepted for publication in Clinical infectious diseases following peer review. The version of record Chroboczek T, Lacoste M, Wackenheim C, Challan-Belval T, Amar B, Boisson T, Hubac J, Leduc D. et al. Corticosteroids in patients with COVID-19: what about the control group? Clin Infect Dis. 2020 Jun 16: ciaa768. is available online at: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa768/5858270 DOI: 10.1093/cid/ciaa768CoronavirusCorticosteroidesinfo:eu-repo/semantics/articlehttp://dx.doi.org/10.1093/cid/ciaa768info:eu-repo/semantics/openAccess